Literature DB >> 8102356

Plasma concentrations of glutamate and its metabolites in patients with Alzheimer's disease.

D E Miulli1, D Y Norwell, F N Schwartz.   

Abstract

Neurologic and psychologic tests without brain tissue biopsy do not establish the diagnosis of Alzheimer's disease. This pilot study demonstrates significant increases in the activity of plasma glutamate dehydrogenase and the plasma concentrations of aspartate, glutamate, and alpha-ketoglutarate in nursing home residents with previously diagnosed Alzheimer's disease when compared with that in other nursing home residents without Alzheimer's disease who had no complicating conditions. Plasma concentrations of gamma-aminobutyric acid, glutamine, and activities of plasma glutamate decarboxylase, glutaminase, and glutamine synthetase were not significantly different in the two groups. A discriminant analysis number, based on the four significantly different compounds, is obtained that may be used as the basis for an inexpensive, non-invasive, and accurate screening test for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102356

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  11 in total

1.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

2.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

3.  Alteration of plasma glutamate and glutamine levels in children with high-functioning autism.

Authors:  Chie Shimmura; Shiro Suda; Kenji J Tsuchiya; Kenji Hashimoto; Koji Ohno; Hideo Matsuzaki; Keiko Iwata; Kaori Matsumoto; Tomoyasu Wakuda; Yosuke Kameno; Katsuaki Suzuki; Masatsugu Tsujii; Kazuhiko Nakamura; Nori Takei; Norio Mori
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

4.  A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model.

Authors:  Nailya S Gliyazova; Eun Y Huh; Gordon C Ibeanu
Journal:  BMC Neurosci       Date:  2013-09-02       Impact factor: 3.288

Review 5.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

Review 6.  Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications.

Authors:  Victoria Bunik; Artem Artiukhov; Vasily Aleshin; Garik Mkrtchyan
Journal:  Biology (Basel)       Date:  2016-12-14

Review 7.  Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.

Authors:  Wei Bai; Yuan-Guo Zhou
Journal:  Front Mol Neurosci       Date:  2017-12-05       Impact factor: 5.639

8.  Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.

Authors:  Gaetano Corso; Adriana Cristofano; Nadia Sapere; Giancarlo la Marca; Antonella Angiolillo; Michela Vitale; Roberto Fratangelo; Teresa Lombardi; Carola Porcile; Mariano Intrieri; Alfonso Di Costanzo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-05-04

9.  Obesity as a Risk Factor for Alzheimer's Disease: Implication of Leptin and Glutamate.

Authors:  Ana Lloret; Paloma Monllor; Daniel Esteve; Ana Cervera-Ferri; Maria-Angeles Lloret
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

10.  Targeted metabolomics analysis of postoperative delirium.

Authors:  Bridget A Tripp; Simon T Dillon; Min Yuan; John M Asara; Sarinnapha M Vasunilashorn; Tamara G Fong; Eran D Metzger; Sharon K Inouye; Zhongcong Xie; Long H Ngo; Edward R Marcantonio; Towia A Libermann; Hasan H Otu
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.